Oral Antidiabetic Agents in Gestational Diabetes Mellitus- Shifting of Paradigm?

Authors

  • MR Amin Assistant Professor of Medicine, Dhaka Medical College, Dhaka
  • MZ Hossain Assistant Professor of Medicine, Dhaka Medical College, Dhaka
  • MT Miah Assistant Professor of Medicine, Dhaka Medical College, Dhaka
  • R Yasmin Assistant Professor of Medicine, Dhaka Medical College, Dhaka
  • MFI Chowdhury Associate Professor of Medicine, Dhaka Medical College, Dhaka
  • MA Hoque Associate Professor of Medicine, Dhaka Medical College, Dhaka

DOI:

https://doi.org/10.3329/jdmc.v17i2.6596

Keywords:

Diabetes mellitus

Abstract

Diabetes mellitus is one of the most common medical complications of pregnancy; gestational diabetes mellitus (GDM) accounts for approximately 90-95% of all cases. The incidence of gestational diabetes is increasing. It has been demonstrated that good metabolic control maintained throughout pregnancy can reduce maternal and fetal complications in diabetes Traditionally, insulin therapy has been considered the gold standard for management There has been a traditional reluctance to recommend oral antidiabetic drugs for the management of hyperglycaemia in gestational diabetes mellitus. The medical management of gestational diabetes is still evolving, and recent randomized controlled trials have given a glimse of hope for woman who likes to avoid insulin and prefer oral agents.

The current short acting insulin analogs lispro and aspart are safe, but there are only limited data to support the use of long acting insulin analogs. There are randomized controlled trials which have demonstrated efficacy of the oral agents glyburide and metformin. Whilst shortterm data have not demonstrated adverse effects of glyburide and metformin on the fetus, and they are increasingly being used in pregnancy, there remain long-term concerns regarding their potential for harm. This controversy related article gives an overview of the rationale for use of oral antidiabetic agents in the treatment of gestational diabetes.

DOI: 10.3329/jdmc.v17i2.6596

J Dhaka Med Coll. 2008; 17(2) : 127-130

Downloads

Download data is not yet available.
Abstract
507
PDF
612

Downloads

How to Cite

Amin, M., Hossain, M., Miah, M., Yasmin, R., Chowdhury, M., & Hoque, M. (2010). Oral Antidiabetic Agents in Gestational Diabetes Mellitus- Shifting of Paradigm?. Journal of Dhaka Medical College, 17(2), 127–130. https://doi.org/10.3329/jdmc.v17i2.6596

Issue

Section

Article of Special Interest